Author

Ahmad-Bin Salam

Tuskegee University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Amit MitraiD· 1 shared Clayton Clopton YatesiD· 1 shared Farnaz HemmatiiD· 1 shared Farshad AmiriiD· 1 shared Feng LiiD· 1 shared Isra A. ElhussiniD· 1 shared Panagiotis MistriotisiD· 1 shared Robert D. ArnoldiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Amit MitraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and stem-like cells in lethal prostate cancer

Suman Mazumder, Taraswi Mitra Ghosh, Ujjal Kumar Mukherjee, Sayak Chakravarti, Farshad Amiri, Farnaz Hemmati, Panagiotis Mistriotis, Isra A. Elhussin, Ahmad-Bin Salam, Windy Marie Dean-Colomb, Feng Li, Clayton Clopton Yates, Robert D. Arnold, Amit Mitra

The paper uses scRNAseq and pharmacogenomics to identify FK866 as a potential drug for aggressive prostate cancer, showing its efficacy against drug-resistant and stem-like cells.

bioRxiv · Jul 20, 2022 · PreprintMolecular Biology